Export to Outlook
|
|
Start Date:
|
Saturday, January 26, 2013
|
|
|
End Date:
|
Sunday, January 27, 2013
|
|
|
Time:
|
All day
|
|
|
Duration:
|
All day
|
|
|
Recurrence:
|
One-time event
|
|
|
Venue:
|
Hilton San Diego Resort on Mission Bay
|
|
|
City:
|
San Diego
|
|
|
State:
|
CA
|
|
|
Country:
|
|
|
|
Cost:
|
|
|
|
Company:
|
Scripps Conference Services & CME
|
|
|
Name:
|
Andrew Johnson
|
|
|
Address:
|
11025 N. Torrey Pines Rd.
|
|
|
Address 2:
|
Suite 200, SCRC200
|
|
|
City:
|
La Jolla
|
|
|
State:
|
CA
|
|
|
Postal Code:
|
92037
|
|
|
Country:
|
|
|
|
Phone:
|
858-652-5400
|
|
|
Fax:
|
858-652-5565
|
|
|
Email:
|
med.edu@scrippshealth.org
|
|
|
Website:
|
http://www.scripps.org/events/melanoma-2013
|
|
|
Program Director(s):
|
Hubert T. Greenway, Jr., MD; Terry L. Barrett, MD
|
|
|
Description:
|
Course Overview
As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.
Conference Highlights:
• Plenary talks from nationally recognized experts
• Case presentations and expert discussion
• Ample question and answer time with course faculty
• Networking opportunities among colleagues
Educational Objectives
After attending this activity, participants should be able to:
• Demonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.
• Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.
• Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.
• Illustrate the new melanoma staging system and how it impacts disease management.
• Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.
• Determine techniques to improve patient compliance.
• Incorporate new therapies and treatment modalities for advanced melanoma patients including surgical techniques.
• Navigate the medico-legal aspects of caring for the melanoma patient.
Target Audience
• Dermatologists
• Pathologists
• Dermatopathologists
• Primary Care Physicians
• Oncologists
|
|
|
Future Events:
|
|
|
|
Meeting Type:
|
US
|
|
|
Event Type
|
AAD Category 1 Recognized and AMA Accredited
|
|
|
AAD CME Program #:
|
393400
|
|